Growth of the Coronary Stent Industry in India

Since the 2000s, the coronary stent market in India has grown tremendously. India is now among the top five markets for coronary stents globally. Several multinational companies as well as local manufacturers produce a wide variety of drug-eluting and bare-metal stents catering to all budget segments. It is estimated that over 500,000 coronary stenting procedures are performed annually in India currently. The coronary stent industry is a multi-billion dollar business in India and is expected to witness continued strong growth driven by rising heart disease burden as well as increased healthcare access and insurance coverage. Leading domestic stent brands such as Sahajanand, Biotronik, and Scient have emerged.

Improving Access and Outcomes with Coronary Stenting

Indian Coronary Stents Widened stent availability at affordable prices has greatly improved access to cardiac treatments for all strata of society in India. While expensive imported drug-eluting stents continue to be used frequently in large private hospitals, public hospitals predominantly use lower priced bare-metal and locally manufactured drug-eluting stents. Various state and central government health insurance schemes also cover cardiac stenting procedures. This has translated to notably lower death rates from heart attacks in India compared to the past. However, outcomes in India still lag behind developed countries and more efforts are needed to reduce risk factors and strengthen follow-up care post stenting.

New Technologies and Trends in Coronary Stenting

Continued advancement of stent technology aims to further optimize outcomes. Newer limus-eluting and biodegradable polymer drug-eluting stents have been shown to reduce risks of late stent thrombosis. Completely biodegradable stents dissolving into the artery wall after performing their structural function are under development and hold promise. Increased use of intravascular ultrasound and fractional flow reserve aids interventional cardiologists in India to better plan stenting strategy. Treating complex multi-vessel and chronic total occlusions with newer dedicated stents and adjunctive techniques also contributes to expanded treatment eligibility. Upcoming areas of focus are stent treatment of heart attack, left main coronary artery stenting, as well as pediatric coronary interventions.

Explore more information on this topic, Please visit- 
https://www.pressreleasebulletin.com/india-coronary-stents-size-and-share-analysis-growth-trends-and-forecasts/